Liver patients may have memory problems
May 7th, 2010 - 5:40 pm ICT by ANIWashington, May 7 (ANI): A study led by a Loyola University Health System researcher has revealed that more than half of patients who have cirrhosis of the liver also display neurocognitive impairments such as short-term memory loss.
Loyola neuropsychologist Christopher Randolph, and colleagues found that 54 percent of 301 cirrhosis patients who were tested scored below the 10th percentile for their age and education on a test that measures neurocognitive abilities.
“Neurocognitive impairment is a major issue in patients with liver disease. This can affect patients’ ability to do everyday tasks such as working, driving or managing their finances,” Randolph, a clinical professor in the Department of Neurology at Loyola University Chicago Stritch School of Medicine.
Neurocognitive impairment in liver patients is called hepatic encephalopathy. It is believed to be caused by toxins such as ammonia that diseased livers do not clear from the body.
Randolph’s study is the first to document how liver patients compare with the general population.
Liver patients from multiple centers nationwide were given a test developed by Randolph called the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS).
The widely used paper-and-pencil test takes 20 to 25 minutes and measures memory, attention, language and visual-spatial functions. It includes tasks such as identifying line drawings of common objects, repeating lists of digits, copying geometrical figures and recalling a story.
In the general population, the average score on RBANS tests is 100. Among liver patients in Randolph’s study who had neurocognitive impairments, the average score was 74. This is lower than the average score of patients with early-stage Alzheimer’s disease.
Prevalence of neurocognitive impairment was independent of age, gender, educational level or severity of the underlying disease.
The findings are a subset of a larger study to determine whether an experimental compound called AST-120 benefits liver patients who have neurocognitive impairments. AST-120 absorbs ammonia and other toxins. Patients have been randomly assigned to receive AST-120 or a placebo.
The results of the study were reported during the Digestive Disease Week meeting of physicians and researchers in New Orleans. (ANI)
- Genetic variation linked to liver cirrhosis in alcoholic Caucasians identified - Dec 17, 2010
- 'Smartphones can be a boon for visually impaired' - May 17, 2012
- Brain bypass regenerates lost brain tissue - Apr 25, 2011
- Memory training can overcome forgetfulness - Mar 02, 2012
- Peg or two lowers risk of liver disease - Apr 23, 2012
- Chronic liver disease cure on the horizon - Mar 06, 2012
- Mild memory problem ups risk of death - Sep 06, 2011
- Study sheds new light on the causes of chronic liver cirrhosis - Mar 14, 2011
- Liver ailments rise in Kerala - Dec 21, 2011
- Non-alcoholic steatohepatitis linked to liver cancer - May 26, 2010
- Stem cells from skin, blood regenerate faltering liver - May 12, 2011
- Memory deteriorates faster in life's last two years - Apr 05, 2012
- Vitamin E may help treat common liver disease - May 01, 2010
- Specific Vitamin E dose can benefit nonalcoholic steatohepatitis patients - Apr 29, 2010
- Daily dose of blueberries may guarantee improved memory - Jan 30, 2010
Tags: chicago stritch school, disease prevalence, diseased livers, geometrical figures, line drawings, liver disease, liver patients, loyola university chicago, loyola university chicago stritch school of medicine, loyola university health, loyola university health system, memory problems, pencil test, short term memory, short term memory loss, spatial functions, stage alzheimer, stritch school of medicine, university chicago stritch school, university health system